February 7, 2022 09:45 AM
Dr. Reddy’s Laboratories today announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India.
Sputnik Light is a one-dose vaccine and the same as the first component—recombinant human adenovirus serotype number 26 (rAd26)—of the two-dose Sputnik V vaccine. Following its Phase III clinical trial of the single-shot Sputnik Light vaccine in India, Dr. Reddy’s had submitted its application for approval to the DCGI in December 2021, in addition to data from clinical trial in Russia.
At 09:35 hrs Dr Reddy’s Laboratories was quoting at Rs 4,327.25, down Rs 23.05, or 0.53 percent on the BSE.